IP Library Granted Patent US 9,309,561
Granted Patent B2
US 9,309,561 · App. 14/098,519 · Granted Apr 12, 2016

Methods and kits using extended rhodamine dyes

Inventors: Joe Y. L. Lam (Castro Valley, CA); Scott C. Benson (Alameda, CA); Steven M. Menchen (Fremont, CA)
Assignee: Applied Biosystems, LLC
C12Q1/6816C07D209/60C07D221/08C07D221/10C07D471/06C07D487/06C07D491/14C07H19/04C07H21/00C09B11/24C12Q1/68Y10S435/968Y10S435/975Y10S436/80Y10T436/143333
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,309,561
App. No.
14/098,519
Granted
Apr 12, 2016
Kind
B2
Abstract

Extended rhodamine compounds exhibiting favorable fluorescence characteristics having the structure are disclosed. In addition, novel intermediates for synthesis of these dyes are disclosed, such intermediates having the structure In addition, methods of making and using the dyes as fluorescent labels are disclosed.

Claims (77)

1. A method of polynucleotide sequencing comprising the steps of:

forming a mixture of a first, a second, a third, and a fourth class of polynucleotides such that:

each polynucleotide in the first class includes a 3′-terminal dideoxyadenosine labeled with a first dye;

each polynucleotide in the second class includes a 3′-terminal dideoxycytidine and is labeled with a second dye;

each polynucleotide in the third class includes a 3′-terminal dideoxyguanosine and is labeled with a third dye; and

each polynucleotide in the fourth class includes a 3′-terminal dideoxythymidine and is labeled with a fourth dye;

wherein one of the first, second, third or fourth dyes is an extended rhodamine dye having a structure of one of the following formulae:

wherein

R 1 , R 2 , R 3 , R 4 , R 5 , R 6 , R 7 , R 9 , R 10 , R 11 , and R 13 when taken alone are selected from —H, alkyl, alkyl independently substituted with one or more Z 1 , heteroalkyl, heteroalkyl independently substituted with one or more Z 1 , aryl, aryl independently substituted with one or more Z 1 , heteroaryl, heteroaryl independently substituted with one or more Z 1 , arylalkyl, arylalkyl independently substituted with one or more Z 1 , heteroarylalkyl, heteroarylalkyl independently substituted with one or more Z 1 , halogen, —OS(O) 2 OR, —S(O) 2 OR, —S(O) 2 R, —S(O) 2 NR, —S(O)R, —OP(O)O 2 RR, —P(O)O 2 RR, —C(O)OR, —NR 2 , —NR 3 , —NC(O)R, —C(O)R, —C(O)NR 2 , —CN, and —OR; or

R 1 taken together with R 2 , Y 1 , or Y 2 ; or

R 4 taken together with R 3 , Y 3 , or Y 4 ; or

R 5 taken together with R 6 , Y 3 , or Y 4 ; or

R 6 taken together with R 7 , Y 3 , or Y 4 ; or

R 10 taken together with R 9 or R 11 ; or

R 11 taken together with Y 1 , or Y 2 ; or

R 13 taken together with Y 3 or Y 4 are selected from alkyleno, alkyleno independently substituted with one or more Z 1 , heteroalkyleno, heteroalkyleno independently substituted with one or more Z 1 , aryleno, aryleno independently substituted with one or more Z 1 , heteroaryleno, and heteroaryleno independently substituted with one or more Z 1 ;

R 8 is selected from —H, alkyl, alkyl independently substituted with one or more Z 1 , heteroalkyl, heteroalkyl independently substituted with one or more Z 1 , aryl, aryl independently substituted with one or more Z 1 , heteroaryl, heteroaryl independently substituted with one or more Z 1 , arylalkyl, arylalkyl independently substituted with one or more Z 1 , heteroarylalkyl, and heteroarylalkyl independently substituted with one or more Z 1 ;

Y 1 , Y 2 , Y 3 , Y 4 when taken alone are selected from —H, alkyl, alkyl independently substituted with one or more Z 1 , heteroalkyl, heteroalkyl independently substituted with one or more Z 1 , aryl, aryl independently substituted with one or more Z 1 , heteroaryl, heteroaryl independently substituted with one or more Z 1 , arylalkyl, arylalkyl independently substituted with one or more Z 1 , heteroarylalkyl, and heteroarylalkyl independently substituted with one or more Z 1 ; or

Y 1 taken together with R 1 , R 11 or Y 2 ; or

Y 2 taken together with R 1 , R 11 or Y 1 ; or

Y 3 taken together with R 4 , R 5 , R 6 , R 13 or Y 4 ; or

Y 4 taken together with R 4 , R 5 , R 6 , R 13 or Y 3 are selected from alkyleno, alkyleno independently substituted with one or more Z 1 , heteroalkyleno, heteroalkyleno independently substituted with one or more Z 1 , aryleno, aryleno independently substituted with one or more Z 1 , heteroaryleno, and heteroaryleno independently substituted with one or more Z 1 ;

Z 1 is selected from —R, halogen, —OS(O) 2 OR, —SO 2 OR, —SO 2 R, —SO 2 NR, —S(O)R, —OP(O)O 2 RR, —P(O)O 2 RR, —CO 2 R, —NR 2 , —NR 3 , —NC(O)R, —C(O)R, —C(O)NR 2 , —CN, —O and —OR, wherein R is independently selected from —H, alkyl, heteroalkyl, aryl, heteroaryl, arylalkyl, heteroarylalkyl and linkage to the polynucleotide; and

R is independently selected from —H, alkyl, heteroalkyl, aryl, heteroaryl, arylalkyl, heteroarylalkyl and a linkage to the labeled polynucleotide wherein the linkage is attached to the extended rhodamine compound at R 1 , R 4 , R 5 , R 6 , R 7 , R 8 , R 9 , R 10 , Y 1 , Y 2 , Y 3 , or Y 4 ; and

wherein each of the other of the four dyes is spectrally resolvable from the extended rhodamine dye and from each other;

electrophoretically separating the labeled polynucleotides thereby forming bands of similarly sized polynucleotides;

illuminating the bands with an illumination beam capable of causing the dyes to fluoresce; and

identifying the classes of the labeled polynucleotides in the bands by the fluorescence spectrum of the dyes.

2. The method of claim 1 , wherein the extended rhodamine dye is configured to be excited by an excitation light source having a wavelength greater than about 630 nm.

3. The method of claim 1 , wherein the one or more labeled polynucleotides is labeled at a nucleobase of the polynucleotide, and further wherein:

(a) when the nucleobase comprises a purine base, the linking group connecting the extended rhodamine dye to the nucleobase is attached to the 8-position of the purine base;

(b) when the nucleobase comprises a 7-deazapurine base, the linking group connecting the extended rhodamine dye to the nucleobase is attached to the 7-position of the 7-deazapurine base; and

(c) when the nucleobase comprises a pyrimidine base, the linking group connecting the extended rhodamine dye to the nucleobase is attached to the 5-position of the pyrimidine base.

4. The method of claim 1 , wherein the linking group connecting the extended rhodamine dye to a nucleobase of the one or more labeled polynucleotide is attached to R 8 of the extended rhodamine dye.

5. The method of claim 1 , wherein the linking group connecting the extended rhodamine dye to the labeled polynucleotide is an alkynylamino- derivatized or alkenyl-derivatized linkage.

6. The method of claim 1 , wherein the one or more labeled polynucleotides has a structure of one of the following formulae:

wherein NUC is a nucleobase of the one or more labeled polynucleotides;

D is the extended rhodamine dye;

R 3 is selected from the group consisting of —H and lower alkyl;

X is selected from one of the following formulae:

n is an integer of 1 to 5; and

R 1 is —H, lower alkyl, or protecting group.

7. A method for sequencing a nucleic acid sequence comprising:

forming a mixture of extended labeled primers by hybridizing a nucleic acid sequence with a fluorescently labeled oligonucleotide primer in the presence of deoxynucleotide triphosphates, at least one dideoxynucleotide triphosphate and a DNA polymerase, the DNA polymerase extending the primer with the deoxynucleotide triphosphates until a dideoxynucleotide triphosphate is incorporated which terminates extension of the primer;

separating the mixture of extended primers; and

determining the sequence of the nucleic acid sequence by fluorescently measuring the mixture of extended primers formed;

wherein the fluorescently labeled oligonucleotide primer comprises an extended rhodamine dye having a structure of the formula:

wherein

R 1 , R 2 , R 3 , R 4 , R 5 , R 6 , R 7 , R 9 , R 10 , R 11 , and R 13 when taken alone are selected from —H, alkyl, alkyl independently substituted with one or more Z 1 , heteroalkyl, heteroalkyl independently substituted with one or more Z 1 , aryl, aryl independently substituted with one or more Z 1 , heteroaryl, heteroaryl independently substituted with one or more Z 1 , arylalkyl, arylalkyl independently substituted with one or more Z 1 , heteroarylalkyl, heteroarylalkyl independently substituted with one or more Z 1 , halogen, —OS(O) 2 OR, —S(O) 2 OR, —S(O) 2 R, —S(O) 2 NR, —S(O)R, —OP(O)O 2 RR, —P(O)O 2 RR, —C(O)OR, —NR 2 , —NR 3 , —NC(O)R, —C(O)R, —C(O)NR 2 , —CN, and —OR; or

R 1 taken together with R 2 , Y 1 , or Y 2 ; or

R 4 taken together with R 3 , Y 3 , or Y 4 ; or

R 5 taken together with R 6 , Y 3 , or Y 4 ; or

R 6 taken together with R 7 , Y 3 , or Y 4 ; or

R 10 taken together with R 9 or R 11 ; or

R 11 taken together with Y 1 , or Y 2 ; or

R 13 taken together with Y 3 or Y 4 are selected from alkyleno, alkyleno independently substituted with one or more Z 1 , heteroalkyleno, heteroalkyleno independently substituted with one or more Z 1 , aryleno, aryleno independently substituted with one or more Z 1 , heteroaryleno, and heteroaryleno independently substituted with one or more Z 1 ;

R 8 is selected from —H, alkyl, alkyl independently substituted with one or more Z 1 , heteroalkyl, heteroalkyl independently substituted with one or more Z 1 , aryl, aryl independently substituted with one or more Z 1 , heteroaryl, heteroaryl independently substituted with one or more Z 1 , arylalkyl, arylalkyl independently substituted with one or more Z 1 , heteroarylalkyl, and heteroarylalkyl independently substituted with one or more Z 1 ;

Y 1 , Y 2 , Y 3 , Y 4 when taken alone are selected from —H, alkyl, alkyl independently substituted with one or more Z 1 , heteroalkyl, heteroalkyl independently substituted with one or more Z 1 , aryl, aryl independently substituted with one or more Z 1 , heteroaryl, heteroaryl independently substituted with one or more Z 1 , arylalkyl, arylalkyl independently substituted with one or more Z 1 , heteroarylalkyl, and heteroarylalkyl independently substituted with one or more Z 1 ; or

Y 1 taken together with R 1 , R 11 or Y 2 ; or

Y 2 taken together with R 1 , R 11 or Y 1 ; or

Y 3 taken together with R 4 , R 5 , R 6 , R 13 or Y 4 ; or

Y 4 taken together with R 4 , R 5 , R 6 , R 13 or Y 3 are selected from alkyleno, alkyleno independently substituted with one or more Z 1 , heteroalkyleno, heteroalkyleno independently substituted with one or more Z 1 , aryleno, aryleno independently substituted with one or more Z 1 , heteroaryleno, and heteroaryleno independently substituted with one or more Z 1 ;

Z 1 is selected from —R, halogen, —OS(O) 2 OR, —SO 2 OR, —SO 2 R, —SO 2 NR, —S(O)R, —OP(O)O 2 RR, —P(O)O 2 RR, —CO 2 R, —NR 2 , —NR 3 , —NC(O)R, —C(O)R, —C(O)NR 2 , —CN, —O and —OR, wherein R is independently selected from —H, alkyl, heteroalkyl, aryl, heteroaryl, arylalkyl, heteroarylalkyl and linkage to the fluorescently labeled primer; and

wherein R is independently selected from —H, alkyl, heteroalkyl, aryl, heteroaryl, arylalkyl, heteroarylalkyl and a linkage to the fluorescently labeled primer; wherein the linkage is attached to the extended rhodamine compound at R 1 , R 4 , R 5 , R 6 , R 7 , R 8 , R 9 , R 10 , Y 1 , Y 2 , Y 3 , or Y 4 ; and wherein linkage is attached to the fluorescently labeled primer at a nucleobase of the primer:

(a) when the nucleobase comprises a purine base, the linkage connecting the extended rhodamine dye to the nucleobase is attached to the 8-position of the purine base;

(b) when the nucleobase comprises a 7-deazapurine base, the linkage connecting the extended rhodamine dye to the nucleobase is attached to the 7-position of the 7-deazapurine base; and

(c) when the nucleobase comprises a pyrimidine base, the linkage connecting the extended rhodamine dye to the nucleobase is attached to the 5-position of the pyrimidine base.

8. The method of claim 7 , wherein the extended rhodamine dye is configured to be excited by an excitation light source having a wavelength greater than about 630 nm.

9. The method of claim 7 , wherein the linking group connecting the extended rhodamine dye to a nucleobase of the fluorescently labeled primer is attached to R 8 of the extended rhodamine dye.

10. The method of claim 7 , wherein the linking group connecting the extended rhodamine dye to the fluorescently labeled primer is an alkynylamino- derivatized or alkenyl-derivatized linkage.

11. The method of claim 7 , wherein the fluorescently labeled primer has a structure of one of the following formulae:

wherein NUC is a nucleobase of the fluorescently labeled primer;

D is the extended rhodamine dye;

R 3 is selected from the group consisting of —H and lower alkyl;

X is selected from one of the following formulae:

n is an integer of 1 to 5; and R 1 is —H, lower alkyl, or protecting group.

12. The method of claim 7 , wherein the separating step is an electrophoretic size-dependent separation process.

Assignments (4)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 22, 2014
From: LAM, JOE Y.L.; BENSON, SCOTT C.; MENCHEN, STEVEN M.
To: THE PERKIN-ELMER CORPORATION
Reel/Frame 032731/0119 →
MERGER Recorded Apr 22, 2014
From: APPLERA CORPORATION
To: APPLIED BIOSYSTEMS INC.
Reel/Frame 032731/0162 →
MERGER Recorded Apr 22, 2014
From: ATOM ACQUISITION CORPORATION; APPLIED BIOSYSTEMS INC.
To: APPLIED BIOSYSTEMS, LLC
Reel/Frame 032731/0190 →
CHANGE OF NAME Recorded Apr 22, 2014
From: THE PERKIN-ELMER CORPORATION
To: APPLERA CORPORATION
Reel/Frame 032737/0239 →
Continuity (6)
Continuation 13365554 · Feb 3, 2012
Continuation 12846773 · Jul 29, 2010
Division 10925411 · Aug 24, 2004
Division 09780600 · Feb 9, 2001
Division 09325243 · Jun 3, 1999
Related Publication 20140171336A1 · Jun 19, 2014